AAAAAA

   
Results: 1-25 | 26-48
Results: 1-25/48
COMBINATION CIPROFLOXACIN AND METRONIDAZOLE FOR ACTIVE CROHNS-DISEASE
Authors: GREENBLOOM SL STEINHART AH GREENBERG GR
Citation: Sl. Greenbloom et al., COMBINATION CIPROFLOXACIN AND METRONIDAZOLE FOR ACTIVE CROHNS-DISEASE, Canadian journal of gastroenterology, 12(1), 1998, pp. 53-56
SOMATOSTATIN-14 MODULATES ACID-DEPENDENT INHIBITION OF MEAL-STIMULATED GASTRIN VIA MUSCARINIC PATHWAYS IN DOGS
Authors: FUNG LC GREENBERG GR
Citation: Lc. Fung et Gr. Greenberg, SOMATOSTATIN-14 MODULATES ACID-DEPENDENT INHIBITION OF MEAL-STIMULATED GASTRIN VIA MUSCARINIC PATHWAYS IN DOGS, Regulatory peptides, 74(2-3), 1998, pp. 159-166
INTERIM-REPORT ON SUPPORTIVE-EXPRESSIVE GROUP-PSYCHOTHERAPY FOR INFLAMMATORY BOWEL-DISEASE
Authors: MAUNDER RG LANCEE WJ ESPLEN MJ GREENBERG GR
Citation: Rg. Maunder et al., INTERIM-REPORT ON SUPPORTIVE-EXPRESSIVE GROUP-PSYCHOTHERAPY FOR INFLAMMATORY BOWEL-DISEASE, Psychosomatic medicine, 60(1), 1998, pp. 127-127
BONE-MINERAL DENSITY IN CROHNS-DISEASE PATIENTS RECEIVING LONG-TERM BUDESONIDE
Authors: CINO M GREENBERG GR
Citation: M. Cino et Gr. Greenberg, BONE-MINERAL DENSITY IN CROHNS-DISEASE PATIENTS RECEIVING LONG-TERM BUDESONIDE, Gastroenterology, 114(4), 1998, pp. 3902-3902
IMPROVEMENT IN INFLAMMATORY BOWEL DISEASE-RELATED QUALITY-OF-LIFE, DAYS OFF WORK AND SOMATIZATION ASSOCIATED WITH GROUP-PSYCHOTHERAPY
Authors: MAUNDER RG LANCEE WJ ESPLEN MJ GREENBERG GR
Citation: Rg. Maunder et al., IMPROVEMENT IN INFLAMMATORY BOWEL DISEASE-RELATED QUALITY-OF-LIFE, DAYS OFF WORK AND SOMATIZATION ASSOCIATED WITH GROUP-PSYCHOTHERAPY, Gastroenterology, 114(4), 1998, pp. 4236-4236
CONTRIBUTION OF HLA CLASS-II GENES TO SUSCEPTIBILITY TO ULCERATIVE-COLITIS (UC) IN A CANADIAN INFLAMMATORY BOWEL-DISEASE (IBD) POPULATION
Authors: SILVERBERG MS MURPHY J STEINHART AH MCLEOD RS GRIFFITHS A MIREA L SZYDA JZ BULL SB WILLIAMS CN GREENBERG GR COHEN Z WADE JA SIMINOVITCH KA RIOUX JD DALY MJ HUDSON T LANDER ES
Citation: Ms. Silverberg et al., CONTRIBUTION OF HLA CLASS-II GENES TO SUSCEPTIBILITY TO ULCERATIVE-COLITIS (UC) IN A CANADIAN INFLAMMATORY BOWEL-DISEASE (IBD) POPULATION, Gastroenterology, 114(4), 1998, pp. 4442-4442
GENETIC SUSCEPTIBILITY IN A CANADIAN INFLAMMATORY BOWEL-DISEASE (IBD)POPULATION
Authors: SILVERBERG MS STEINHART AH MCLEOD RS GRIFFITHS A MIREA L BULL SB WILLIAMS CN GREENBERG GR COHEN Z SIMINOVITCH KA RIOUX JD DALY MJ GREEN T STONE V HUDSON T LANDER ES
Citation: Ms. Silverberg et al., GENETIC SUSCEPTIBILITY IN A CANADIAN INFLAMMATORY BOWEL-DISEASE (IBD)POPULATION, Gastroenterology, 114(4), 1998, pp. 4443-4443
SOMATOSTATIN RECEPTOR SUBTYPE-5 MEDIATES INHIBITION OF PEPTIDE YY SECRETION FROM INTESTINAL CULTURES
Authors: CHISOLM C GREENBERG GR
Citation: C. Chisolm et Gr. Greenberg, SOMATOSTATIN RECEPTOR SUBTYPE-5 MEDIATES INHIBITION OF PEPTIDE YY SECRETION FROM INTESTINAL CULTURES, Gastroenterology, 114(4), 1998, pp. 4648-4648
NUTRIENT AND PEPTIDE REGULATION OF SOMATOSTATIN-28 SECRETION FROM INTESTINAL CULTURES
Authors: BRUBAKER PL GRONAU EA ASA SL GREENBERG GR
Citation: Pl. Brubaker et al., NUTRIENT AND PEPTIDE REGULATION OF SOMATOSTATIN-28 SECRETION FROM INTESTINAL CULTURES, Endocrinology, 139(1), 1998, pp. 148-155
GLUCAGON-LIKE PEPTIDE-1-(7-36) AMIDE AND PEPTIDE YY MEDIATE INTRADUODENAL FAT-INDUCED INHIBITION OF ACID-SECRETION IN DOGS
Authors: FUNG LC CHISHOLM C GREENBERG GR
Citation: Lc. Fung et al., GLUCAGON-LIKE PEPTIDE-1-(7-36) AMIDE AND PEPTIDE YY MEDIATE INTRADUODENAL FAT-INDUCED INHIBITION OF ACID-SECRETION IN DOGS, Endocrinology, 139(1), 1998, pp. 189-194
TRUNCATED AND FULL-LENGTH GLUCAGON-LIKE PEPTIDE-1 (GLP-1) DIFFERENTIALLY STIMULATE INTESTINAL SOMATOSTATIN RELEASE
Authors: BRUBAKER PL EFENDIC S GREENBERG GR
Citation: Pl. Brubaker et al., TRUNCATED AND FULL-LENGTH GLUCAGON-LIKE PEPTIDE-1 (GLP-1) DIFFERENTIALLY STIMULATE INTESTINAL SOMATOSTATIN RELEASE, Endocrine, 6(1), 1997, pp. 91-95
HEALTH-RELATED CONCERNS OF PEOPLE WHO RECEIVE PSYCHOLOGICAL SUPPORT FOR INFLAMMATORY BOWEL-DISEASE
Authors: MAUNDER RG DEROOY EC TONER BB GREENBERG GR STEINHART AH MCLEOD RS COHEN Z
Citation: Rg. Maunder et al., HEALTH-RELATED CONCERNS OF PEOPLE WHO RECEIVE PSYCHOLOGICAL SUPPORT FOR INFLAMMATORY BOWEL-DISEASE, Canadian journal of gastroenterology, 11(8), 1997, pp. 681-685
NUTRITION IN INFLAMMATORY BOWEL-DISEASE
Authors: STEINHART AH GREENBERG GR
Citation: Ah. Steinhart et Gr. Greenberg, NUTRITION IN INFLAMMATORY BOWEL-DISEASE, Current opinion in gastroenterology, 13(2), 1997, pp. 140-145
CHARACTERIZATION OF SOMATOSTATIN RECEPTOR SUBTYPES MEDIATING INHIBITION OF NUTRIENT-STIMULATED GASTRIC-ACID AND GASTRIN IN DOGS
Authors: FUNG LC GREENBERG GR
Citation: Lc. Fung et Gr. Greenberg, CHARACTERIZATION OF SOMATOSTATIN RECEPTOR SUBTYPES MEDIATING INHIBITION OF NUTRIENT-STIMULATED GASTRIC-ACID AND GASTRIN IN DOGS, Regulatory peptides, 68(3), 1997, pp. 197-203
BUDESONIDE CONTROLLED ILEAL RELEASE PROLONGED REMISSION IN CROHNS-DISEASE - A POOLED ANALYSIS
Authors: FEAGAN B GREENBERG GR LOFBERG R FERGUSON A PERSSON T
Citation: B. Feagan et al., BUDESONIDE CONTROLLED ILEAL RELEASE PROLONGED REMISSION IN CROHNS-DISEASE - A POOLED ANALYSIS, Gut, 41, 1997, pp. 17-17
RISK AND SIGNIFICANCE OF ENDOSCOPIC RADIOLOGICAL EVIDENCE OF RECURRENT CROHNS-DISEASE/
Authors: MCLEOD RS WOLFF BG STEINHART AH CARRYER PW OROURKE K ANDREWS DF BLAIR JE CANGEMI JR COHEN Z CULLEN JB CHAYTOR RG GREENBERG GR JAFFER NM JEEJEEBHOY KN MACCARTY RL READY RL WEILAND LH
Citation: Rs. Mcleod et al., RISK AND SIGNIFICANCE OF ENDOSCOPIC RADIOLOGICAL EVIDENCE OF RECURRENT CROHNS-DISEASE/, Gastroenterology, 113(6), 1997, pp. 1823-1827
BUDESONIDE CONTROLLED ILEAL RELEASE PROLONGS REMISSION IN CROHNS-DISEASE (CD) - A POOLED ANALYSIS
Authors: FEAGAN B GREENBERG GR LOFBERG R FERGUSON A PERSSON T
Citation: B. Feagan et al., BUDESONIDE CONTROLLED ILEAL RELEASE PROLONGS REMISSION IN CROHNS-DISEASE (CD) - A POOLED ANALYSIS, Gastroenterology, 112(4), 1997, pp. 970-970
DISEASE CHARACTERISTICS OF FAMILIAL AND NONFAMILIAL CROHNS-DISEASE
Authors: STEINHART AH MCLEOD RS GREENBERG GR SIMINOVITCH K GRIFFITHS AM BULL S BLAIR J CRUZ C BARTON P COHEN Z
Citation: Ah. Steinhart et al., DISEASE CHARACTERISTICS OF FAMILIAL AND NONFAMILIAL CROHNS-DISEASE, Gastroenterology, 112(4), 1997, pp. 1096-1096
PRELIMINARY-REPORT ON THE MOUNT-SINAI HOSPITAL INFLAMMATORY BOWEL-DISEASE GENETICS PROJECT
Authors: MCLEOD RS STEINHART AH SIMINOVITCH KA GREENBERG GR BULL SB BLAIR JE CRUZ CR BARTON PM COHEN Z
Citation: Rs. Mcleod et al., PRELIMINARY-REPORT ON THE MOUNT-SINAI HOSPITAL INFLAMMATORY BOWEL-DISEASE GENETICS PROJECT, Diseases of the colon & rectum, 40(5), 1997, pp. 553-557
ORAL BUDESONIDE AS MAINTENANCE TREATMENT FOR CROHNS-DISEASE - A PLACEBO-CONTROLLED, DOSE-RANGING STUDY
Authors: GREENBERG GR FEAGAN BG MARTIN F SUTHERLAND LR THOMSON ABR WILLIAMS N NILSSON LG PERSSON T
Citation: Gr. Greenberg et al., ORAL BUDESONIDE AS MAINTENANCE TREATMENT FOR CROHNS-DISEASE - A PLACEBO-CONTROLLED, DOSE-RANGING STUDY, Gastroenterology, 110(1), 1996, pp. 45-51
VAGAL CONTROL OF FASTING SOMATOSTATIN LEVELS
Authors: CHUNG SA GREENBERG GR DIAMANT NE
Citation: Sa. Chung et al., VAGAL CONTROL OF FASTING SOMATOSTATIN LEVELS, Neurogastroenterology and motility, 7(2), 1995, pp. 73-78
TOTAL ENTERAL NUTRITION SUPPORT IMPROVES BODY-COMPOSITION OF PATIENTSWITH ACTIVE CROHNS-DISEASE
Authors: ROYALL D GREENBERG GR ALLARD JP BAKER JP JEEJEEBHOY KN
Citation: D. Royall et al., TOTAL ENTERAL NUTRITION SUPPORT IMPROVES BODY-COMPOSITION OF PATIENTSWITH ACTIVE CROHNS-DISEASE, JPEN. Journal of parenteral and enteral nutrition, 19(2), 1995, pp. 95-99
METHOTREXATE FOR THE TREATMENT OF CROHNS-DISEASE
Authors: FEAGAN BG ROCHON J FEDORAK RN IRVINE EJ WILD G SUTHERLAND L STEINHART AH GREENBERG GR GILLIES R HOPKINS M HANAUER SB MCDONALD JWD
Citation: Bg. Feagan et al., METHOTREXATE FOR THE TREATMENT OF CROHNS-DISEASE, The New England journal of medicine, 332(5), 1995, pp. 292-297
PROPHYLACTIC MESALAMINE TREATMENT DECREASES POSTOPERATIVE RECURRENCE OF CROHNS-DISEASE
Authors: MCLEOD RS WOLFF BG STEINHART AH CARRYER PW OROURKE K ANDREWS DF BLAIR JE CANGEMI JR COHEN Z CULLEN JB CHAYTOR RG GREENBERG GR JAFFER NM JEEJEEBHOY KN MACCARTY RL READY RL WEILAND LH
Citation: Rs. Mcleod et al., PROPHYLACTIC MESALAMINE TREATMENT DECREASES POSTOPERATIVE RECURRENCE OF CROHNS-DISEASE, Gastroenterology, 109(2), 1995, pp. 404-413
CIPROFLOXACIN AND METRONIDAZOLE - COMBINATION ANTIBIOTIC-THERAPY FOR ILEOCOLONIC CROHNS-DISEASE
Authors: GREENBLOOM SL STEINHART AH GREENBERG GR
Citation: Sl. Greenbloom et al., CIPROFLOXACIN AND METRONIDAZOLE - COMBINATION ANTIBIOTIC-THERAPY FOR ILEOCOLONIC CROHNS-DISEASE, Gastroenterology, 108(4), 1995, pp. 827-827
Risultati: 1-25 | 26-48